|
Baseline Characteristics
|
All participants (n = 1,239)
|
With ASVD (n = 369)
|
Without ASVD (n = 870)
|
P value
|
|---|
|
Age (years)
|
75.20 ± 2.71
|
75.73 ± 2.87
|
74.97 ± 2.61
|
< 0.001
|
|
Body mass index (kg/m2)
|
27.21 ± 4.68
|
27.82 ± 5.29
|
26.95 ± 4.38
|
0.003
|
|
Systolic blood pressure (mm Hg)
|
137.76 ± 18.00
|
140.73 ± 18.27
|
136.54 ± 17.76
|
< 0.001
|
|
Current smoker (yes/no)
|
6 (0.0)
|
3 (0.0)
|
3 (0.0)
|
0.371
|
|
Diabetes (yes/no)
|
85 (6.9)
|
38 (10.3)
|
47 (5.4)
|
0.002
|
|
Prevalent ASVD (yes/no)
|
150 (12.1)
|
90 (24.4)
|
60 (6.9)
|
< 0.001
|
|
MDRD eGFR (mL/min/1.73 m
2
)
|
65.20 ± 14.54
|
62.42 ± 13.72
|
66.37 ± 14.73
|
< 0.001
|
|
CKD-EPI eGFR (mL/min/1.73 m
2
)
|
66.26 ± 13.47
|
63.54 ± 13.76
|
67.42 ± 13.19
|
< 0.001
|
- Results are mean ± SD or number and (%). P values are a comparison of those with and without ASVD hospitalizations at 10 years by univariate ANOVA or Chi squared test where appropriate. ASVD atherosclerotic vascular disease, eGFR estimated glomerular filtration rate, MDRD Modification of Diet in Renal Disease and CKD-EPI Chronic Kidney Disease EPIdemiology.
